Stock KERYX BIOPHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Keryx Biopharmaceuticals

Equities

US4925151015

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Akebia Therapeutics, Inc., Keryx Biopharmaceuticals, Inc. and Averoa SAS Enter into License Agreement
CI
Keryx Biopharmaceuticals, Inc. Announces Settlement of Auryxia Patent Litigation with Panion & Bf Biotech Inc
CI
Keryx Biopharmaceuticals, Inc., and Panion & BF Biotech, Inc Enters into License Agreement with Par Pharmaceutical, Inc
CI
Keryx Biopharmaceuticals, Inc.(NasdaqCM:KERX) dropped from S&P Biotechnology Select Industry Index
CI
Keryx Biopharmaceuticals, Inc.(NasdaqCM:KERX) dropped from S&P TMI Index
CI
Keryx Biopharmaceuticals, Inc.(NasdaqCM:KERX) dropped from S&P Global BMI Index
CI
Keryx Biopharmaceuticals, Inc. Announces Executive Changes
CI
Keryx Biopharmaceuticals, Inc.(NasdaqGM:KERX) dropped from Russell 2000 Index
CI
Keryx Biopharmaceuticals, Inc.(NasdaqGM:KERX) dropped from Russell 3000 Index
CI
Keryx Biopharmaceuticals, Inc.(NasdaqGM:KERX) dropped from NASDAQ Composite Index
CI
Akebia Therapeutics Inc. (‘Akebia’) completed the acquisition of Keryx Biopharmaceuticals Inc. (‘Keryx’) from Baupost Group Securities LLC (‘Baupost’), Abrams Capital LLC, The Vanguard Group Inc. and other shareholders in a merger of equals transaction.
CI
Keryx Biopharmaceuticals Stockholders Approve Merger with Akebia Therapeutics
GL
Keryx Biopharmaceuticals : ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
PU
ISS Recommends that Keryx Biopharmaceuticals Stockholders Vote “FOR” the Proposed Merger with Akebia Therapeutics
GL
Keryx Biopharmaceuticals : Akebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined Company
BU
Keryx Biopharmaceuticals, Inc. and Akebia Therapeutics, Inc. Announce Board Changes
CI
Keryx Biopharmaceuticals Announces Third Quarter 2018 Financial Results
GL
Keryx Biopharmaceuticals, Inc. Reports Unaudited and Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018
CI
Keryx Biopharmaceuticals to Release Third Quarter 2018 Financial Results on Thursday, November 8, 2018
GL
Keryx Biopharmaceuticals Announces Participation in an Upcoming Investor Conference
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Keryx Biopharmaceuticals